Calderon, Jonathan A.

HRN: 27-58-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/13/2025
08/20/2025
IV
1.5 Gram
Q8h
CAP MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: